Latest Asx News

HeraMED Limited has raised $1.98 million through a discounted share placement to fund its digital maternity care platform's commercial growth across the US, Australia, and Europe.

Chilwa Minerals has raised A$4.1 million through a private placement to fast-track exploration and development at its multi-commodity Chilwa Project in Malawi, with directors backing the raise subject to shareholder approval.

Washington H. Soul Pattinson and Brickworks Limited have unveiled plans to merge via inter-conditional schemes, creating a new ASX-listed entity, Topco. The combination promises enhanced liquidity, portfolio diversification, and a stronger balance sheet, with expert endorsement affirming its benefits for shareholders.

Terra Uranium Limited (ASX – T92) reveals significant historic mineralisation of tin, tungsten, molybdenum, and silver at its Deepwater Project in New South Wales, underpinning its strategic acquisition of Dundee Resources Pty Ltd.

Brickworks Limited and Washington H. Soul Pattinson have unveiled plans to combine under a newly capitalised ASX-listed entity, Topco, aiming to simplify their complex cross-shareholding and unlock shareholder value. Shareholders are set to vote on the scheme in September, with the merger expected to enhance liquidity and deliver dividend accretion.

Unith Ltd has acknowledged a technical breach of its trading policy following a director's share purchase during a closed period, prompting a comprehensive review of its governance framework.

Adherium Limited has raised A$0.35 million through an institutional placement, supplementing its recent entitlement offer to strengthen its financial position and support growth initiatives.

Javelin Minerals has announced a significant 15% increase in recoverable gold ounces at its Eureka Gold Project, alongside a 32% rise in grade, setting the stage for enhanced production and cashflow in 2026.

Papyrus Australia Ltd has announced a $262,000 capital raise through a share placement and unlisted options, aiming to strengthen its working capital and research efforts.

Syntara Limited’s trading suspension has been lifted as the company lodged its quarterly activity and cash flow reports for June 2025, reopening its shares to market activity.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

X2M Connect Limited’s X2MO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s regulatory standing and next steps.